Acuren Corporation Ltd (NYSE:TIC) does about 1.16M shares in volume on a normal day but saw 1788085 shares change hands in the recent trading day. The company now has a market cap of 1.41B USD. Its current market price is $11.58, marking a decrease of -3.34% compared to the previous close of $11.98. The 52 week high reached by this stock is $14.28 whilst the lowest price level in 52 weeks is $8.76.
Acuren Corporation Ltd (TIC) has a 20-day trading average at $11.12 and the current price is -18.91% off the 52-week high compared with 32.27% distance from its 52-week low. If we look at the stock’s price movements over the week, volatility stands at 4.62%, which decreases to 4.22% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 57.56 to suggest the stock is neutral.
The consensus objective for the share price is $13.83, suggesting that the stock has a potential upside of 16.27% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 21, 2025 when UBS initiated the stock to “Neutral” and issued a price target of $13.
The current price level is 4.17%, 7.35%, and 3.99% away from its SMA20, SMA50, and SMA200 respectively, with the TIC price moving above the 50-day SMA on current market day. Acuren Corporation Ltd (TIC) stock is up 2.03% over the week and 7.52% over the past month. Its price is -9.18% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0.19 and 0.52 for whole year. Expected sales for next quarter are $316.12M, which analysts say will come at $1.14B for the current fiscal year and next year at $1.2B. In addition, estimates put the company’s current quarterly revenue at an average of $308.4M.
To reach the target analysts have set, the stock logically needs to grow 16.27 percent from here.
Outstanding shares total 121.41M with insiders holding 15.88% of the shares and institutional holders owning 75.29% of the company’s common stock. The forward price to earnings ratio is 22.78.
